1. Metabolic Syndrome Is A Key Determinant Of Coronary Microvascular Function In Patients With Stable Coronary Disease Undergoing PCI Narbeh Melikian…
Bunyad Haider, M.D.FACC;FACP Professor and Chairman Dept of Medicine UMDNJ-New Jersey Medical School Coronary Artery Disease Evolving Management Strategies Medicate, Dilate,…